Latest operating income for CMRAW: $-9.1M.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023
Comera Life Sciences Holdings- Warrants (19/05/2027)'s operating income stands at $-9.1M as of September 2023. That compares with $-11M in the prior-year period — up 16.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Comera Life Sciences Holdings- Warrants (19/05/2027) reported $-9.1M in operating income versus $-11M a year earlier — a 16.7% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
That compares with $-11M in the prior-year period — up 16.7% year over year. Sustained growth in operating income can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Comera Life Sciences Holdings- Warrants (19/05/2027)'s operating income evolved across reporting periods, while the comparison chart places CMRAW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.